High FDG uptake predicts poorer survival in locally advanced nonsmall cell lung cancer patients undergoing curative radiotherapy, independently of tumor size

Ulger, Sukran; Demirci, Nilgun; Eroglu, Fatma; Cengiz, Huriye; Tunc, Mustafa; Tatci, Ebru; Yilmaz, Ulku; Cetin, Eren; Avci, Emine; CENGİZ, MUSTAFA

doi:10.1007/s00432-014-1591-9

High FDG uptake predicts poorer survival in locally advanced nonsmall cell lung cancer patients undergoing curative radiotherapy, independently of tumor size

Atıf İçin Kopyala

Ulger S., Demirci N. Y. , Eroglu F. N. , Cengiz H. H. , Tunc M., Tatci E., ...Daha Fazla

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, cilt.140, ss.495-502, 2014 (SCI İndekslerine Giren Dergi)

Cilt numarası: 140 Konu: 3
Basım Tarihi: 2014
Doi Numarası: 10.1007/s00432-014-1591-9
Dergi Adı: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Sayfa Sayıları: ss.495-502

Özet

Objectives Despite radical radiotherapy and chemotherapy (CT), the prognosis of locally advanced nonsmall cell lung cancer (NSCLC) is poor. New prognostic indicators are being looked forward to improve the survival. [18F]-fluorodeoxyglucose (FDG) uptake on PET/CT has been observed as a prognostic marker mainly in early-stage disease. Our aim was to examine the prognostic value of FDG uptake in locally advanced NSCLC.